2026-03-28 (六) 13:30 ~ 16:05

線上會議連結：https://us06web.zoom.us/meeting/register/Vb_9a2pNQCqwMFUrIEJwlg#/registration

實體地點：高雄和逸Cozzie 高雄中山館30樓(請於下方點擊報名)

CRSwNP and severe eosinophilic asthma (SEA) share a common type 2 inflammatory pathway driven by eosinophils, reflecting the concept of united airway disease. Anti-IL-5 therapies target eosinophilic inflammation and offer a promising strategy for managing patients with both upper and lower airway involvement. This session will review the role of IL-5 in eosinophilic airway disease and discuss clinical experiences in optimizing treatment for patients with CRSwNP and SEA.